These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1229669)

  • 1. [Clinical significance of the exacerbation reaction in syphilis].
    Frishman MP; Dunaeva GA
    Vestn Dermatol Venerol; 1975 Dec; (12):36-41. PubMed ID: 1229669
    [No Abstract]   [Full Text] [Related]  

  • 2. [Some data on the clinical characteristics of the Herxheimer exacerbation reaction].
    Gaukhman VD; Miliavskiĭ AI
    Vestn Dermatol Venerol; 1973 Mar; 47(3):49-53. PubMed ID: 4730099
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical and therapeutic aspects of syphilis].
    Storck H
    Schweiz Rundsch Med Prax; 1971 Mar; 60(13):412-9. PubMed ID: 5087745
    [No Abstract]   [Full Text] [Related]  

  • 4. Penicillin in the treatment of syphilis. The experience of three decades.
    Idsoe O; Guthe T; Willcox RR
    Bull World Health Organ; 1972; 47 Suppl(Suppl):1-68. PubMed ID: 4575351
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immediate and long-term results of intensive treatment of patients with contageous variants of syphilis].
    Vasil'ev TV; Vinokurov IN; Kotrovskaia LG; Toporovskiĭ LM
    Vestn Dermatol Venerol; 1982; (1):74-7. PubMed ID: 7072363
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of splenin for the purpose of immunocorrection in patients with seroresistance following syphilis treatment].
    Bakhmet'eva TM; Lonshakov IuI; Petrova IV
    Vestn Dermatol Venerol; 1988; (10):38-42. PubMed ID: 3223051
    [No Abstract]   [Full Text] [Related]  

  • 7. [Accelerated treatment of patients with infectious forms of syphilis].
    Frishman MP; Zadorozhnyĭ BA; Logunov VP; Lavrik AU; Glukhen'kiĭ BT
    Vestn Dermatol Venerol; 1984 Feb; (2):71-5. PubMed ID: 6720079
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical features and mechanism of Lukachevich-Herxheimer exacerbation reaction].
    Miliavskiĭ AI; Shevchenko VP; Terekhov EI; Lomakin VG; Miliavskiĭ IuA
    Vestn Dermatol Venerol; 1977 Apr; (4):84-8. PubMed ID: 899227
    [No Abstract]   [Full Text] [Related]  

  • 9. [Time period for clinicoserological follow-up of patients finishing treatment for syphilis].
    Mirakhmedov UM; Liuban BL; Khashimov BI; Shadlovskaia TI
    Vestn Dermatol Venerol; 1981; (10):59-62. PubMed ID: 7303873
    [No Abstract]   [Full Text] [Related]  

  • 10. [ACTH as a prophylactic against the Jarisch-Herxheimer reaction].
    Sylvester E
    Z Haut Geschlechtskr; 1969 Feb; 44(4):125-6. PubMed ID: 4311756
    [No Abstract]   [Full Text] [Related]  

  • 11. [Continuous method of treatment of recurrent and early latent syphilis].
    Glavinskaia TA; Frigo IV; Novikova SI; Pavlovskaia VE; Rezaĭkina AV
    Vestn Dermatol Venerol; 1983 Apr; (4):29-33. PubMed ID: 6868814
    [No Abstract]   [Full Text] [Related]  

  • 12. [The dynamic serological reactions after treating patients with early forms of syphilis by the single-course shortened reserve method].
    Bednova VN; Amantaev NB; Timchenko GF; Babiĭ AV; Viktorova GA
    Vestn Dermatol Venerol; 1990; (11):42-6. PubMed ID: 2288154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Syphilis as a diagnostic and therapeutic problem].
    Greither A
    Med Klin; 1965 Oct; 60(43):1721-5. PubMed ID: 5326326
    [No Abstract]   [Full Text] [Related]  

  • 14. [Remote results of continuous penicillin treatment of patients with contagious forms of syphilis].
    Kalantaevskaia KA; Kaliuzhnaia LD; Koziĭ LM; Sobolevskaia OP; Poltoratskiĭ VG
    Vestn Dermatol Venerol; 1974 Nov; (11):24-9. PubMed ID: 4446720
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinico-immunologic characteristics of patients with seroresistant syphilis].
    Markin IIa; Lezvinskaia EM; Pataridze IF; Sochugov BM
    Vestn Dermatol Venerol; 1989; (5):52-5. PubMed ID: 2773583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Seroresistant forms of syphilis].
    Ovchinnikov NM; Vasil'ev TV; Sazonova LV; Vinokurov IN; Korbut SE
    Vestn Dermatol Venerol; 1980 May; (5):68-72. PubMed ID: 7385965
    [No Abstract]   [Full Text] [Related]  

  • 17. [Criteria for the cure of syphilis].
    Ovchinnikov NM; Vasil'ev TV; Korbut SE; Sazonova LV; Vinokurov IN
    Vestn Dermatol Venerol; 1978 Aug; (8):28-32. PubMed ID: 695910
    [No Abstract]   [Full Text] [Related]  

  • 18. [Improved treatment of patients with recurrent secondary syphilis].
    Glavinskaia TA; Frigo NV; Novikova SI; Rezaĭkina AV
    Vestn Dermatol Venerol; 1988; (9):40-3. PubMed ID: 3213218
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical significance of nonspecific syphilis serological reaction].
    Király K; Rácz I; Vereckei I; Tokodi I
    Orv Hetil; 1966 Jul; 107(31):1441-8. PubMed ID: 5943628
    [No Abstract]   [Full Text] [Related]  

  • 20. [Seroresistant syphilis].
    Ovchinnikov NM
    Vestn Dermatol Venerol; 1971 Aug; 45(8):35-41. PubMed ID: 4944558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.